Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.
about
Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer riskTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerHigh expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology.Combination therapy in combating cancer.Therapeutic targeting of Bcl-2 family for treatment of B-cell malignancies.Activation of AKT/ERK confers non-small cell lung cancer cells resistance to vinorelbine
P2860
Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Antitumor efficacy of oblimers ...... an non-small cell lung cancer.
@en
type
label
Antitumor efficacy of oblimers ...... an non-small cell lung cancer.
@en
prefLabel
Antitumor efficacy of oblimers ...... an non-small cell lung cancer.
@en
P2093
P1476
Antitumor efficacy of oblimers ...... an non-small cell lung cancer.
@en
P2093
Jason R Sartor
Lawrence D Mayer
Rebecca Ng
Sophia Tan
YanPing Hu
P304
P356
10.1158/1078-0432.CCR-04-1036
P407
P577
2004-11-01T00:00:00Z